Seminars in Arthritis and Rheumatism This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The Nomenclature of the Basic Disease Elements of Gout: A Content Analysis of Contemporary Medical Journals
This study aimed to identify these elements and examine how they are labelled in contemporary medical literature. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 28, 2018 Category: Rheumatology Authors: David Bursill, William J. Taylor, Robert Terkeltaub, Nicola Dalbeth Source Type: research

Medications Received by Patients with Juvenile Dermatomyositis
This study evaluated therapies received, changes of treatment over time, and factors associated with medication choices in JDM. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 28, 2018 Category: Rheumatology Authors: Takayuki Kishi, Nastaran Bayat, Michael M. Ward, Adam M. Huber, Lan Wu, Gulnara Mamyrova, Ira N. Targoff, William J. Warren-Hicks, Frederick W. Miller, Lisa G. Rider, for the Childhood Myositis Heterogeneity Study Group Source Type: research

Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement
We read with great interest the report by Albayda and colleagues [1] describing the association between serum anti-mitochondrial antibodies (AMA) and a specific phenotype of inflammatory myopathy with heart involvement. In this retrospective study conducted on a large population of patients followed at the Johns Hopkins Myositis Center in the years 2009 –2015, 7 cases tested positive for AMA. This result was first described using a myositis serum autoantibody panel assayed by the Oklahoma Medical Research Foundation (OMRF), based on the combination of techniques such as immunoprecipitation (IP) with HeLa cell lysate, imm...
Source: Seminars in Arthritis and Rheumatism - March 28, 2018 Category: Rheumatology Authors: Angela Ceribelli, Natasa Isailovic, Maria De Santis, Carlo Selmi Source Type: research

Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement
We read with great interest the report by Albayda and Colleagues [1] describing the association between serum anti-mitochondrial antibodies (AMA) and a specific phenotype of inflammatory myopathy with heart involvement. In this retrospective study conducted on a large population of patients followed at the Johns Hopkins Myositis Center in the years 2009 –2015, 7 cases tested positive for AMA. This result was first described using a myositis serum autoantibody panel assayed by the Oklahoma Medical Research Foundation (OMRF), based on the combination of techniques such as immunoprecipitation (IP) with HeLa cell lysate, imm...
Source: Seminars in Arthritis and Rheumatism - March 28, 2018 Category: Rheumatology Authors: Angela Ceribelli, Natasa Isailovic, Maria De Santis, Carlo Selmi Source Type: research

Diagnostic utility of automated indirect immunofluorescence compared to manual indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis
This study aimed to review and compare the analytical and clinical performance of automated indirect immunofluorescence (AIIF) and manual indirect immunofluorescence (MIIF) as anti-nuclear antibody screening assays for patients with systemic rheumatic diseases (SRDs), such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 27, 2018 Category: Rheumatology Authors: Jinmi Kim, Woonhyoung Lee, Geun-Tae Kim, Hyon-Suk Kim, Soyoung Ock, In-Soo Kim, Seri Jeong Source Type: research

Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care
To estimate patient acceptable symptom state (PASS) and minimal clinically important difference (MCID) for patient-reported outcomes in systemic sclerosis (SSc). (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 27, 2018 Category: Rheumatology Authors: Camille Daste, Fran çois Rannou, Luc Mouthon, Katherine Sanchez, Alexandra Roren, Vincent Tiffreau, Éric Hachulla, Philippe Thoumie, Jean Cabane, Emmanuel Chatelus, Jean Sibilia, Serge Poiraudeau, Christelle Nguyen Source Type: research

No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study
While tocilizumab may increase serum lipid levels, recent studies do not suggest a link between tocilizumab use and clinical cardiovascular risk in patients with rheumatoid arthritis (RA). (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 22, 2018 Category: Rheumatology Authors: Seoyoung C. Kim, Daniel H. Solomon, James R. Rogers, Sara Gale, Micki Klearman, Khaled Sarsour, Sebastian Schneeweiss Source Type: research

A systematic review of viral exposures as a risk for rheumatoid arthritis
Different viral exposures have been implicated in the etiology of rheumatoid arthritis (RA). Evidence relating to the association between putative viral exposures and the development of RA was reviewed. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 22, 2018 Category: Rheumatology Authors: F.M. Kudaeva, M.R. Speechley, J.E. Pope Source Type: research

Editorial Board
(Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 20, 2018 Category: Rheumatology Source Type: research